Your browser doesn't support javascript.
loading
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model.
Wemlinger, Scott M; Parker Harp, Chelsea R; Yu, Bo; Hardy, Ian R; Seefeldt, Matthew; Matsuda, Jennifer; Mingueneau, Michael; Spilker, Kerri A; Cameron, Thomas O; Larrick, James W; Getahun, Andrew; Cambier, John C.
Afiliação
  • Wemlinger SM; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO.
  • Parker Harp CR; Multiple Sclerosis and Neurorepair Research Unit, Biogen, Cambridge, MA.
  • Yu B; Panorama Research Institute, Sunnyvale, CA.
  • Hardy IR; Miltenyi Biotec, Bergisch Gladbach, Germany.
  • Seefeldt M; The Charles Gates Biomanufacturing Facility, Aurora, CO.
  • Matsuda J; Department of Biomedical Research, National Jewish Health, Denver, CO; and.
  • Mingueneau M; Multiple Sclerosis and Neurorepair Research Unit, Biogen, Cambridge, MA.
  • Spilker KA; Biologics Drug Discovery, Biogen, Cambridge, MA.
  • Cameron TO; Biologics Drug Discovery, Biogen, Cambridge, MA.
  • Larrick JW; Panorama Research Institute, Sunnyvale, CA.
  • Getahun A; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO.
  • Cambier JC; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO; John.Cambier@cuanschutz.edu.
J Immunol ; 208(7): 1566-1584, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35321883

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article